Jiangsu vcare pharmaceutical technology co., LTD
Registry sponsor category
Industry
- Other names
- Jiangsu vcare pharmaceutical technology co., LTD
- Company name
- Jiangsu vcare pharmaceutical technology co., LTD
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (35)
- A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects
- A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects
- A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.
- A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
- A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
- A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
- A Phase Ib, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of VC004 Capsules for Pain in Bone Metastases
- A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo
- Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects
- Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis
- Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects
- Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
- Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
- Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
- Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
- Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
- Food Effect and Relative Bioavailability Study of VC004 Capsules in Healthy Adult Subjects
- Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects
- Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects
- Pharmacokinetic/Pharmacodynamic Study of Vicagrel Capsules and Clopidogrel Tablets in Healthy CYP2C19 Normal Metabolizers